Stimuli-responsive Hydrogels for Targeted Antibiotic Delivery in Bone Tissue Engineering
- PMID: 40836182
- DOI: 10.1208/s12249-025-03218-0
Stimuli-responsive Hydrogels for Targeted Antibiotic Delivery in Bone Tissue Engineering
Abstract
Bone tissue engineering (BTE) faces critical challenges in managing infections such as osteomyelitis, which complicate healing and compromise implant success. Conventional antibiotic therapies often fail to achieve effective localized drug concentrations without systemic toxicity. Stimuli-responsive hydrogels have emerged as a transformative solution, offering spatiotemporally controlled, on-demand antibiotic release triggered by environmental cues such as pH, temperature, enzymatic activity, and redox conditions. This review comprehensively analyzes hydrogel classification, design strategies, and their integration within BTE scaffolds. It highlights the synergistic benefits of smart hydrogels in supporting osteogenic differentiation, enhancing vascularization, and combating infection. Key antibiotic delivery mechanisms-from enzyme-sensitive nanocomposites to dual-stimuli systems-are critically examined alongside their pharmacokinetic advantages and limitations. The article also discusses current translational barriers, including mechanical stability, biocompatibility, and regulatory hurdles, while presenting future directions such as biosensing-enabled, 3D-bioprinted, and AI-assisted platforms. Overall, stimuli-responsive hydrogels represent a promising paradigm in precision antibiotic delivery and regenerative bone therapy.
Keywords: bioactive scaffolds; bone tissue engineering; environment-sensitive drug release; localized antibiotic delivery; smart biomaterials; stimuli-responsive hydrogels.
© 2025. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Conflict of interest statement
Declarations: The authors declare that they used AI language tools (ChatGPT and Grammarly Premium) to enhance this manuscript's linguistic clarity and readability. They carefully reviewed and edited all generated text to ensure accuracy and alignment with the research's intended meaning. Conflict of interest: The writers state that they have no known conflicting financial or personal interests that may have impacted the work published in this publication.
References
-
- Masters EA, Trombetta RP, de Mesy Bentley KL, Boyce BF, Gill AL, Gill SR, et al. Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy.” Bone Res. 2019;7:20. https://doi.org/10.1038/s41413-019-0061-z . - DOI - PubMed - PMC
-
- Lian T, Wang Y, Zheng P. Research Progress in Medical Biomaterials for Bone Infections. J Funct Biomater [Internet]. 2025;16:189. Available from: https://www.mdpi.com/2079-4983/16/5/189 .
-
- Lee SS, Du X, Kim I, Ferguson SJ. Scaffolds for bone-tissue engineering. Matter [Internet]. 2022;5:2722–59. Available from: https://www.sciencedirect.com/science/article/pii/S2590238522002983 .
-
- Liu Y-Y, Echeverry-Rendón M. 3D-printed biodegradable polymer scaffolds for tissue engineering: An overview, current stage and future perspectives. Next Mater [Internet]. 2025;8:100647. Available from: https://www.sciencedirect.com/science/article/pii/S2949822825001650 .
-
- Solanki R, Bhatia D. Stimulus-Responsive Hydrogels for Targeted Cancer Therapy. Gels [Internet]. 2024;10:440. Available from: https://www.mdpi.com/2310-2861/10/7/440 .
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
